Publications by authors named "Brit Mollenhauer"

100Publications

In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease.

Neurology 2020 09 3;95(9):e1267-e1284. Epub 2020 Aug 3.

From the Department of Neurology (L.M.C., S.M.), University of Pittsburgh, PA; Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ; University of Iowa (M.C.B., C.S.C., C.C.-G.), Iowa City; Department of Neurology (C.H.A.), Mayo Clinic College of Medicine, Scottsdale, AZ; St. Michael's Hospital (D.G.M.), Toronto, Canada; University of Texas Southwestern Medical School (C.L.W.), Dallas; Icahn School of Medicine at Mount Sinai (J.F.C.), New York, NY; Institute for Neurodegenerative Disorders (D.J.), New Haven, CT; BioLegend Inc. (P.T.), Dedham, MA; Indiana University (T.F.), Indianapolis; The Michael J. Fox Foundation for Parkinson's Research (V.A., C.M.K., L.R., K.D.D.), New York, NY; and Department of Neurology (B.M.), Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000010404DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538226PMC
September 2020

variants in REM sleep behavior disorder: A multicenter study.

Neurology 2020 08 26;95(8):e1008-e1016. Epub 2020 Jun 26.

From the Department of Human Genetics (L.K., U.R., G.A.R., Z.G.-O.), Montreal Neurological Institute (L.K., J.A.R., U.R., E.L., F.A., R.B.P., G.A.R., Z.G.-O.), and Department of Neurology and Neurosurgery (J.A.R., F.A., R.B.P., G.A.R., Z.G.-O.), McGill University, Montréal; Oxford Parkinson's Disease Centre (M.T.M.H.) and Nuffield Department of Clinical Neurosciences (M.T.M.H.), University of Oxford, UK; Sleep Disorders Unit (I.A.), Pitié Salpêtrière Hospital, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière and Sorbonne Universities, Paris; National Reference Center for Narcolepsy, Sleep Unit (Y.D.), Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, University of Montpellier, Inserm U1061, France; Sleep Disorders Unit, Department of Neurology (B.H., A.S.), Medical University of Innsbruck, Austria; Department of Clinical Neurophysiology and Sleep Center (C.C.M.), University Lille North of France, CHU Lille; Sleep Disorder Unit (B.A.), Carémeau Hospital, University Hospital of Nîmes, France; Department of Biomedical and Neuromotor Sciences (DIBINEM) (G.P., E.A.), Alma Mater Studiorum, University of Bologna; IRCCS (G.P., E.A.), Istituto delle Scienze Neurologiche, Bologna; Department of Neurological Sciences (L.F.-S.), Università Vita-Salute San Raffaele, Milan, Italy; Department of Neurology with Institute of Translational Neurology (A.H.), University of Muenster, Germany; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; UC Gardner Neuroscience Institute and Gardner Family Center for Parkinson's Disease and Movement Disorders (A.J.E.), Cincinnati, OH; Sleep and Neurology Unit (V.C.D.C.), Beau Soleil Clinic, Montpellier; EuroMov (V.C.D.C.), University of Montpellier, France; Paracelsus-Elena-Klinik (B.M., F.S.-D., C.T.), Kassel; Department of Neurology (B.M., C.T.), University Medical Centre Goettingen; Department of Neurology (F.S.-D., W.O.), Philipps University, Marburg, Germany; Department of Neurology and Centre of Clinical Neuroscience (K.S., D.K.), Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic; Department of Medical Sciences and Public Health, Sleep Disorder Research Center (M.F., M.P.), University of Cagliari, Italy; Laboratory for Sleep Disorders (F.D., M.V.) and Department of Neurology (F.D., M.V.), St. Dimpna Regional Hospital, Geel, Belgium; Department of Medicine (DAME) (M.T., M.V.), University of Udine, Italy; Department of Clinical and Movement Neurosciences (M.T.), UCL Queen Square Institute of Neurology, London, UK; Clinical Neurology Unit (G.L.G., M.V.), Department of Neurosciences, University Hospital of Udine; DMIF (G.L.G.), University of Udine, Italy; Centre d'Études Avancées en Médecine du Sommeil (J.-F.G., A.D., J.Y.M., R.B.P.), Hôpital du Sacré-Cœur de Montréal; and Departments of Psychology (J.-F.G.), Neurosciences (A.D.), and Psychiatry (J.Y.M.), Université du Québec à Montréal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000010042DOI Listing
August 2020

CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriers.

Transl Neurodegener 2020 05 6;9(1):15. Epub 2020 May 6.

Neurological Disorders Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, P.O. Box 5825, Doha, Qatar.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40035-020-00192-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201744PMC
May 2020

Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide.

Mov Disord Clin Pract 2020 Apr 16;7(3):343-345. Epub 2020 Mar 16.

Paracelsus-Elena-Klinik Klinikstr. 16, 34128 Kassel Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12921DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111582PMC
April 2020

Potential sources of interference with the highly sensitive detection and quantification of alpha-synuclein seeds by qRT-QuIC.

FEBS Open Bio 2020 May 10;10(5):883-893. Epub 2020 Apr 10.

Center for Neuropathology and Prion Research, Ludwig-Maximilians-University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/2211-5463.12844DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193167PMC
May 2020

Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-Synuclein.

Cells 2020 02 5;9(2). Epub 2020 Feb 5.

Ruhr-University, Faculty of Medicine, Medizinisches Proteom-Center, 44801 Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells9020370DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072133PMC
February 2020

Movement disorders in 2019: from antibodies to lifestyle interventions.

Lancet Neurol 2020 01;19(1):10-12

Paracelsus-Elena-Klinik, Kassel, Germany; Department of Neurology, University Medical Center Goettingen, Goettingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(19)30438-7DOI Listing
January 2020

Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's disease.

Neurobiol Dis 2020 02 13;134:104677. Epub 2019 Nov 13.

Department of Neurology, University Medical Center Goettingen, Germany; DZNE, German Center for Neurodegenerative Diseases Goettingen, Germany; Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), Goettingen, Germany; Center for Biostructural Imaging of Neurodegeneration (BIN), University Medical Center Goettingen, Germany; Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University Munich, 81675 Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nbd.2019.104677DOI Listing
February 2020

Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's Disease.

Cell Rep 2019 11;29(7):1767-1777.e8

School of Medicine, National University of Galway, Galway, Ireland; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus Belval, Esch-sur-Alzette, Luxembourg; Division of Microbiology, National University of Galway, Galway, Ireland; APC Microbiome Ireland, Ireland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2019.10.035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856723PMC
November 2019

White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.

Parkinsonism Relat Disord 2019 12 19;69:61-67. Epub 2019 Oct 19.

Institute of Epidemiology and Social Medicine, University of Muenster, Albert-Schweitzer-Campus 1, D-48149, Muenster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2019.10.016DOI Listing
December 2019

SEAweb: the small RNA Expression Atlas web application.

Nucleic Acids Res 2020 01;48(D1):D204-D219

Institute of Medical Systems Biology, Center for Molecular Neurobiology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkz869DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943056PMC
January 2020

A combined miRNA-piRNA signature to detect Alzheimer's disease.

Transl Psychiatry 2019 10 7;9(1):250. Epub 2019 Oct 7.

Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE) Goettingen, 37075, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41398-019-0579-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779890PMC
October 2019

Parkinson's disease biomarkers based on α-synuclein.

J Neurochem 2019 09 28;150(5):626-636. Epub 2019 Jul 28.

Neurological Disorder Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha, Qatar.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jnc.14809DOI Listing
September 2019

CSF and blood biomarkers for Parkinson's disease.

Lancet Neurol 2019 06 10;18(6):573-586. Epub 2019 Apr 10.

Section of Neurology, Department of Medicine, University of Perugia, Perugia, Italy; IRCCS Fondazione Santa Lucia, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(19)30024-9DOI Listing
June 2019

Quantification of Alpha-Synuclein in Biological Fluids by Electrochemiluminescence-Based Detection.

Methods Mol Biol 2019 ;1948:59-68

Paracelsus-Elena-Klinik, Kassel, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-9124-2_6DOI Listing
July 2019

Risk of Parkinson's disease dementia related to level I MDS PD-MCI.

Mov Disord 2019 03 17;34(3):430-435. Epub 2019 Jan 17.

Department of Medical Psychology, Academic Medical Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27617DOI Listing
March 2019

Cerebrospinal fluid biomarker for Parkinson's disease: An overview.

Mol Cell Neurosci 2019 06 10;97:60-66. Epub 2018 Dec 10.

University Medical Center, Department of Neurology, Robert-Koch Strasse 40, 37075 Goettingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mcn.2018.12.005DOI Listing
June 2019

Characterization of Cerebrospinal Fluid via Data-Independent Acquisition Mass Spectrometry.

J Proteome Res 2018 10 12;17(10):3418-3430. Epub 2018 Sep 12.

Ruhr University Bochum, Medical Faculty , Medizinisches Proteom-Center , Universitaetsstrasse 150 , D-44801 Bochum , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jproteome.8b00308DOI Listing
October 2018

Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD).

Am J Geriatr Psychiatry 2018 10 30;26(10):1079-1090. Epub 2018 Jun 30.

Institute of Clinical Psychology and Psychotherapy, Department of Psychology, Technische Universität Dresden, Dresden, Germany; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, Bremen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jagp.2018.06.012DOI Listing
October 2018

The importance of an independent validation cohort for metabolomics biomarker studies.

Mov Disord 2018 05 3;33(5):856. Epub 2018 May 3.

Paracelsus-Elena Klinik, Kassel and University Medical Center, Goettingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27374DOI Listing
May 2018

Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials.

Mov Disord 2018 04;33(4):528-536

Voyager Therapeutics, Cambridge, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27355DOI Listing
April 2018

LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder.

Parkinsonism Relat Disord 2018 07 21;52:98-101. Epub 2018 Mar 21.

Montreal Neurological Institute, McGill University, Montréal, QC, H3A 0G4, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, QC, H3A 0G4, Canada, Canada; Department of Human Genetics, McGill University, H3A 0G4, Montréal, QC, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2018.03.019DOI Listing
July 2018

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

World J Biol Psychiatry 2018 06 27;19(4):244-328. Epub 2017 Oct 27.

a Department of Psychiatry and Psychotherapy , Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg , Erlangen , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15622975.2017.1375556DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916324PMC
June 2018

Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.

Neurology 2017 Nov 13;89(19):1959-1969. Epub 2017 Oct 13.

From the Department of Neurology (B.M.), University Medical Center, Göttingen; Paracelsus-Elena-Klinik (B.M.), Kassel, Germany; Department of Biostatistics (C.J.C.-G., C.S.C.), College of Public Health, University of Iowa, Iowa City; BioLegend Inc. (P.T.), San Diego, CA; Department of Pathology & Laboratory Medicine (L.M.S., J.Q.T.), Center for Neurodegenerative Disease Research, Institute on Aging (L.M.S. , J.Q.T.), and Morris K. Udall Center of Excellence for Parkinson's Disease Research (J.Q.T.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Molecular Genetics Section (A.S.), Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD; The Michael J. Fox Foundation for Parkinson's Research (M.F.), New York, NY; Institute for Neurodegenerative Disorders (K.M.), New Haven, CT; and Department of Neurosciences (D.G.), University of California, San Diego.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004609DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679418PMC
November 2017

The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.

Mov Disord 2018 01 26;33(1):88-98. Epub 2017 Aug 26.

Eco-Systems Biology Research Group, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811909PMC
January 2018

Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease.

Int Rev Neurobiol 2017 8;132:275-294. Epub 2017 Feb 8.

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.irn.2016.12.001DOI Listing
March 2018

Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of α-synuclein in cerebrospinal fluid.

Bioanalysis 2017 Apr 15;9(8):621-630. Epub 2017 May 15.

Department of Neuropathology, University Medical Center, Robert-Koch-Str. 40, 37075 Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/bio-2017-0005DOI Listing
April 2017

The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease.

Biomark Med 2017 Apr 29;11(4):359-368. Epub 2017 Mar 29.

Institute for Neurodegenerative Disorders, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/bmm-2016-0366DOI Listing
April 2017

Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.

Neurology 2017 Apr 22;88(16):1501-1511. Epub 2017 Mar 22.

From the Institute of Neuroscience (L.R., B.G., S.L., A.J.Y., R.M., G.D., T.K.K., D.J.B.), Clinical Ageing Research Unit, Newcastle University; Department of Geriatric Medicine (G.D.), University of Edinburgh, UK; School of Medicine & Menzies Health Institute (T.K.K.), Griffith University, Australia; and Paracelsus-Elena Klinik, Kassel and University Medical Centre (Institute of Neuropathology and Department of Neurosurgery) (B.M.), Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003840DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395075PMC
April 2017

Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease.

Mol Neurobiol 2018 03 21;55(3):2249-2257. Epub 2017 Mar 21.

Clinical Dementia Center, Department of Neurology, University Medical Center Göttingen, Robert Koch Stasse 40, 37075, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12035-017-0479-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840235PMC
March 2018

The depressed brain in Parkinson's disease: Implications for an inflammatory biomarker.

Proc Natl Acad Sci U S A 2017 03 10;114(12):3004-3005. Epub 2017 Mar 10.

Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1700737114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373331PMC
March 2017

Metabolic profiling of body fluids and multivariate data analysis.

MethodsX 2017 20;4:95-103. Epub 2017 Feb 20.

Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg; Braunschweig Integrated Centre of Systems Biology, University of Braunschweig, Rebenring 56, Braunschweig, Germany; Department of Computational Biology of Infection Research, Helmholtz Centre for Infection Research, Braunschweig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mex.2017.02.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329063PMC
February 2017

Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt-Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress.

Mol Neurobiol 2018 01 14;55(1):517-537. Epub 2016 Dec 14.

Department of Neurology, University Medical Center Goettingen (UMG) and German Center for Neurodegenerative Diseases (DZNE) Goettingen, Robert-Koch-Str., 40, 37075, Goettingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12035-016-0294-4DOI Listing
January 2018

Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.

JAMA Neurol 2017 Feb;74(2):163-172

Mitchell Center for Alzheimer's Disease and Related Brain Disorders, The University of Texas School of Medicine at Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2016.4547DOI Listing
February 2017

Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases.

Alzheimers Dement 2017 Jun 18;13(6):710-719. Epub 2016 Nov 18.

Department of Neurology, Clinical Dementia Center, University Medical Center Göttingen, Göttingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Site Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2016.09.013DOI Listing
June 2017

Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies.

J Neurol 2016 Nov 20;263(11):2271-2277. Epub 2016 Aug 20.

Department of Neurology, Clinical Dementia Center, University Medical Center, Georg-August University, Robert Koch Strasse 40, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-016-8259-0DOI Listing
November 2016

Chemical profiling of cerebrospinal fluid by multiple reaction monitoring mass spectrometry.

Analyst 2016 Sep 12;141(18):5252-5. Epub 2016 Aug 12.

Department of Chemistry and Center for Analytical Instrumentation Development (CAID), Purdue University, West Lafayette, IN 47907, USA.

View Article

Download full-text PDF

Source
http://xlink.rsc.org/?DOI=C6AN01618A
Publisher Site
http://dx.doi.org/10.1039/c6an01618aDOI Listing
September 2016

Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned.

Front Aging Neurosci 2016 22;8:147. Epub 2016 Jun 22.

Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of TübingenTübingen, Germany; German Center for Neurodegenerative Diseases, University of TübingenTübingen, Germany; Department of Neurology, Christian-Albrechts-UniversityKiel, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnagi.2016.00147DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916171PMC
July 2016

Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies.

Front Aging Neurosci 2016 27;8:121. Epub 2016 May 27.

Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of TuebingenTuebingen, Germany; German Center for Neurodegenerative Diseases, University of TuebingenTuebingen, Germany; Department of Neurology, Christian-Albrechts UniversityKiel, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnagi.2016.00121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882324PMC
June 2016

Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

Neurology 2016 07 6;87(2):168-77. Epub 2016 May 6.

From Paracelsus-Elena-Klinik (B.M., F.S.-D., T.W., J.E., M.S., E.L., E.T., C.T.), Kassel; Departments of Neurosurgery (B.M., C.T.) and Medical Statistics (T.F.) and Institute of Neuropathology (B.M.), University Medical Centre Göttingen; Psychologische Hochschule Berlin (J.Z.); Department of Neurology/Epileptology and Hertie Institute of Clinical Brain Research (N.K.F.), University of Tübingen, Germany; Clinical Neurochemistry Laboratory (H.Z.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; UCL Institute of Neurology (H.Z.), Queen Square, London, UK; and BioLegend (P.T.), Dedham, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000002651DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940068PMC
July 2016